Experimental Drugs for the Treatment of Hepatitis D

Experimental Drugs for the Treatment of Hepatitis D

Lisa Sandmann,1 Markus Cornberg1,2 1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; 2Centre for Individualised Infection Medicine (CiiM), Helmholtz Centre for Infection Research, Braunschweig, GermanyCorrespondence: Markus CornbergHannover Me...

Full description

Bibliographic Details
Main Authors:	Sandmann L, Cornberg M
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-04-01
Series:	Journal of Experimental Pharmacology
Subjects:	hepatitis delta hbv/hdv coinfection interferon bulevirtide lonafarnib
Online Access:	https://www.dovepress.com/experimental-drugs-for-the-treatment-of-hepatitis-d-peer-reviewed-fulltext-article-JEP

Similar Items

Management of Delta Hepatitis 45 Years after the Discovery of HDV
by: Stefano Brillanti
Published: (2022-03-01)

Hepatitis D virus infection: Pathophysiology, epidemiology and treatment. Report from the first international delta cure meeting 2022Key points
by: Pietro Lampertico, et al.
Published: (2023-09-01)

Bulevirtide in the Treatment of Hepatitis Delta: Drug Discovery, Clinical Development and Place in Therapy
by: Soriano V, et al.
Published: (2023-01-01)

Editorial: The current challenges underlying hepatitis D virus infection
by: Romina Salpini, et al.
Published: (2024-01-01)

A Mathematical Model for Early HBV and -HDV Kinetics during Anti-HDV Treatment
by: Rami Zakh, et al.
Published: (2021-12-01)

Characterization of hepatitis B and delta coinfection in Israel
by: Rachel Shirazi, et al.
Published: (2018-02-01)

Combination of Novel Therapies for HDV
by: Menashe Elazar, et al.
Published: (2022-01-01)

Prevalence of HDV infection in people living with HIV: Data from a multicenter Italian cohort
by: Laura Ambra Nicolini, et al.
Published: (2023-01-01)

Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection
by: Keeffe Emmet B, et al.
Published: (2005-09-01)

Broad-spectrum activity of bulevirtide against clinical isolates of HDV and recombinant pan-genotypic combinations of HBV/HDV
by: Roberto Mateo, et al.
Published: (2023-11-01)

Viral Diagnosis of Hepatitis B and Delta: What We Know and What Is Still Required? Specific Focus on Low- and Middle-Income Countries
by: Amie Ceesay, et al.
Published: (2022-10-01)

Treatment of Chronic Hepatitis D with Bulevirtide—A Fight against Two Foes—An Update
by: Peter Ferenci, et al.
Published: (2022-11-01)

Prevalence of hepatitis B and delta according to HIV-type: a multi-country cross-sectional survey in West Africa
by: Patrick A. Coffie, et al.
Published: (2017-07-01)

Human hepatitis D virus-specific T cell epitopesKey points
by: Matin Kohsar, et al.
Published: (2021-08-01)

Successful treatment of HCV/HBV/HDV-coinfection with pegylated interferon and ribavirin
by: Janine Hartl, et al.
Published: (2012-07-01)

Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)

Efficacy and Safety of Bulevirtide plus Tenofovir Disoproxil Fumarate in Real-World Patients with Chronic Hepatitis B and D Co-Infection
by: Toni Herta, et al.
Published: (2022-04-01)

An update on the prevalence of viral hepatitis B and C among patients attending at tertiary hospital in South India
by: Aleem Ahmed Khan
Published: (2018-01-01)

Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
by: Louis Shekhtman, et al.
Published: (2024-02-01)

Seroprevalence of hepatitis B, C, and D and associated factors in the semi-isolated Yanomami Amazonian indigenous community
by: Mariana Pinheiro Alves Vasconcelos, et al.
Published: (2024-01-01)

Cell Culture Systems for Studying Hepatitis B and Hepatitis D Virus Infections
by: Grace Sanghee Lee, et al.
Published: (2023-07-01)

HDV Pathogenesis: Unravelling Ariadne’s Thread
by: Eirini D. Tseligka, et al.
Published: (2021-04-01)

Prevalence of Hepatitis Delta Virus Infection in Various Groups With HBVinfection in Tehran, Imam Khomeini Hospital (2005-2006)
by: Hadi Ghofrani, et al.
Published: (2008-08-01)

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
by: Linda Munjed Hadi, et al.
Published: (2018-09-01)

Seroprevalence of HDV Infection among HBsAg Positive Blood Donor in Baqubah City, Iraq
by: Linda Munjed Hadi, et al.
Published: (2018-09-01)

Editorial: Viral Hepatitis: Pathophysiology, Prevention, and Control
by: Cheng Kao, et al.
Published: (2021-08-01)

Hepatitis B in Pediatric Population: Observational Retrospective Study in Romania
by: Daniela Păcurar, et al.
Published: (2024-03-01)

Animal delta-like viruses (Kolmioviridae: Deltavirus) and the origin of the human hepatitis D virus (HDV)
by: O. V. Isaeva, et al.
Published: (2021-11-01)

Epidemiology Pattern, Prevalent Genotype Distribution, Fighting Stigma and Control Options for Hepatitis D in Bulgaria and Other European Countries
by: Denitsa Todorova Tsaneva-Damyanova, et al.
Published: (2023-04-01)

Role of hepatitis D virus in persistent alanine aminotransferase abnormality among chronic hepatitis B patients treated with nucleotide/nucleoside analogues
by: Tyng-Yuan Jang, et al.
Published: (2021-01-01)

An overview of Triple infection with Hepatitis B, C and D viruses
by: Kanwal Hifza, et al.
Published: (2011-07-01)

Early Multiphasic HBV Infection Initiation Kinetics Is Not Clone-Specific and Is Not Affected by Hepatitis D Virus (HDV) Infection
by: Masataka Tsuge, et al.
Published: (2019-03-01)

Prevalence of hepatitis B, C and D among patients on highly active antiretroviral drug therapy (HAART) in Calabar metropolis, Nigeria
by: Paul Columba Inyang-Etoh, et al.
Published: (2018-01-01)

Therapeutic Strategies and New Intervention Points in Chronic Hepatitis Delta Virus Infection
by: Zhimin Guo, et al.
Published: (2015-08-01)

Detection and Genetic Characterization of Hepatitis B and D Viruses: A Multi-Site Cross-Sectional Study of People Who Use Illicit Drugs in the Amazon Region
by: Ronylson José S. Silva, et al.
Published: (2021-07-01)

Low prevalence of hepatitis delta infection in Cuban HBsAg carriers: Prospect for elimination
by: Licel de los Ángeles Rodríguez Lay, et al.
Published: (2023-02-01)

Serological detection of hepatitis B and D virus co-infection among patients attending a tertiary health facility at Maiduguri, Nigeria
by: Babajide B. Ajayi, et al.
Published: (2021-02-01)

Treating hepatitis D with bulevirtide – Real-world experience from 114 patients
by: Christopher Dietz-Fricke, et al.
Published: (2023-04-01)

High Prevalence of Hepatitis Delta Virus among Persons Who Inject Drugs, Vietnam
by: Naomi Hall, et al.
Published: (2015-03-01)

Hepatitis D Virus and Hepatocellular Carcinoma
by: Patrizia Farci, et al.
Published: (2021-05-01)